Loading...
Header Logo
Keywords
Last Name
Institution

Sara Vesely

Concepts (560)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Purpura, Thrombotic Thrombocytopenic
52
2017
201
7.820
Why?
Hemolytic-Uremic Syndrome
26
2015
84
3.800
Why?
Purpura, Thrombocytopenic, Idiopathic
22
2018
85
3.670
Why?
Adolescent Behavior
21
2016
62
2.930
Why?
Registries
34
2017
253
2.890
Why?
ADAM Proteins
28
2015
115
2.410
Why?
Plasma Exchange
28
2017
96
2.260
Why?
Thrombocytopenia
12
2018
92
2.050
Why?
Humans
158
2019
18523
1.900
Why?
ADAMTS13 Protein
31
2017
120
1.880
Why?
Adolescent
60
2019
2240
1.760
Why?
Female
107
2019
10316
1.690
Why?
Male
96
2018
9340
1.500
Why?
Parent-Child Relations
11
2015
54
1.470
Why?
Adult
75
2018
5346
1.450
Why?
Oklahoma
35
2018
854
1.380
Why?
Risk-Taking
16
2016
59
1.280
Why?
Pregnancy Complications, Hematologic
5
2018
25
1.200
Why?
Residence Characteristics
5
2014
76
1.150
Why?
Quality of Life
5
2019
257
1.150
Why?
Prospective Studies
18
2019
737
1.130
Why?
Antifibrinolytic Agents
2
2019
8
1.060
Why?
Middle Aged
54
2018
5151
1.020
Why?
Sexual Behavior
8
2012
60
1.000
Why?
Hemorrhage
9
2017
131
0.990
Why?
Drug-Related Side Effects and Adverse Reactions
5
2014
49
0.960
Why?
Tranexamic Acid
1
2019
6
0.950
Why?
Fibrinolytic Agents
3
2018
37
0.940
Why?
Child
28
2019
1542
0.930
Why?
Evidence-Based Medicine
4
2015
134
0.920
Why?
Aged
42
2018
3736
0.910
Why?
Tobacco Use Disorder
4
2014
115
0.890
Why?
Surveys and Questionnaires
23
2019
625
0.880
Why?
Platelet Count
14
2018
88
0.880
Why?
Young Adult
25
2018
1821
0.870
Why?
Social Environment
5
2014
53
0.860
Why?
Thrombosis
4
2016
64
0.850
Why?
Rituximab
8
2017
50
0.840
Why?
Alcohol Drinking
2
2016
121
0.820
Why?
Driving Under the Influence
1
2016
1
0.800
Why?
Blood Alcohol Content
1
2016
1
0.800
Why?
Recurrence
16
2017
243
0.790
Why?
Substance-Related Disorders
4
2014
87
0.760
Why?
Treatment Outcome
17
2019
1615
0.760
Why?
Societies, Medical
2
2016
87
0.740
Why?
Socioeconomic Factors
9
2017
255
0.730
Why?
Family Characteristics
6
2015
33
0.720
Why?
Adrenal Cortex Hormones
7
2017
63
0.720
Why?
Tobacco, Smokeless
2
2013
25
0.710
Why?
Thrombotic Microangiopathies
4
2017
22
0.710
Why?
Risk Factors
16
2017
1455
0.710
Why?
Quinine
5
2017
21
0.680
Why?
Psychology, Adolescent
5
2009
12
0.680
Why?
Tobacco Use
1
2015
29
0.680
Why?
Longitudinal Studies
9
2016
263
0.670
Why?
Metalloendopeptidases
6
2005
33
0.660
Why?
Health Behavior
6
2011
123
0.640
Why?
Age Factors
13
2018
525
0.640
Why?
Cotinine
2
2013
26
0.610
Why?
Hematology
6
2018
20
0.610
Why?
Antibodies, Monoclonal
2
2006
244
0.600
Why?
Pregnancy
13
2018
608
0.590
Why?
Sex Factors
7
2015
339
0.590
Why?
Saliva
2
2013
73
0.590
Why?
Seasons
1
2012
47
0.590
Why?
African Americans
4
2011
348
0.580
Why?
Antibodies, Monoclonal, Murine-Derived
6
2015
39
0.570
Why?
Practice Patterns, Physicians'
4
2018
167
0.550
Why?
ABO Blood-Group System
1
2011
7
0.550
Why?
Sex Education
4
2017
12
0.540
Why?
Genital Neoplasms, Female
3
2018
70
0.510
Why?
Coitus
6
2015
12
0.510
Why?
Pregnancy in Adolescence
4
2017
14
0.480
Why?
Child, Preschool
13
2017
904
0.480
Why?
Contraception Behavior
5
2017
13
0.480
Why?
Contraception
3
2017
15
0.470
Why?
Retrospective Studies
16
2018
1585
0.460
Why?
Menorrhagia
2
2019
3
0.460
Why?
Hematopoietic Stem Cell Transplantation
4
2017
63
0.450
Why?
Social Support
5
2014
93
0.440
Why?
Thromboembolism
3
2017
27
0.440
Why?
Glucocorticoids
3
2006
77
0.420
Why?
Pre-Eclampsia
3
2015
27
0.420
Why?
Cohort Studies
10
2018
622
0.410
Why?
Purpura, Thrombocytopenic
2
2008
7
0.400
Why?
Cognition Disorders
3
2015
176
0.400
Why?
Logistic Models
8
2015
369
0.390
Why?
Review Literature as Topic
2
2014
10
0.380
Why?
Healthcare Disparities
2
2018
61
0.380
Why?
Biomarkers
6
2016
479
0.380
Why?
Parents
8
2014
112
0.380
Why?
Immunoglobulins, Intravenous
4
2017
18
0.380
Why?
United States
12
2017
1660
0.370
Why?
Aged, 80 and over
16
2018
1514
0.360
Why?
Medical Records
2
2017
45
0.360
Why?
Platelet Transfusion
4
2013
22
0.360
Why?
Follow-Up Studies
12
2017
810
0.360
Why?
Midwestern United States
12
2013
40
0.360
Why?
Patient Selection
3
2018
140
0.360
Why?
Clinical Trials as Topic
1
2006
136
0.350
Why?
Autoantibodies
4
2016
383
0.350
Why?
Administration, Oral
4
2019
121
0.350
Why?
Antineoplastic Agents
4
2018
630
0.350
Why?
Depression
2
2016
120
0.340
Why?
Education, Medical, Continuing
2
2016
35
0.340
Why?
Life Change Events
2
2015
32
0.340
Why?
Benchmarking
1
2004
27
0.340
Why?
Health Knowledge, Attitudes, Practice
4
2016
214
0.330
Why?
Splenectomy
5
2013
38
0.330
Why?
Sexual Abstinence
4
2011
5
0.320
Why?
Dexamethasone
1
2003
38
0.310
Why?
Databases as Topic
1
2003
23
0.310
Why?
Cyclophosphamide
1
2003
44
0.310
Why?
Immunosuppressive Agents
2
2003
96
0.310
Why?
Sepsis
3
2012
53
0.300
Why?
Databases, Factual
4
2015
165
0.300
Why?
Randomized Controlled Trials as Topic
3
2017
187
0.300
Why?
Pregnancy Outcome
3
2015
70
0.300
Why?
Infant, Newborn
6
2013
543
0.290
Why?
Menstruation
2
2019
8
0.290
Why?
Blood Platelets
3
2011
116
0.290
Why?
Muscle Relaxants, Central
2
2017
5
0.290
Why?
Sexual Partners
1
2001
13
0.290
Why?
Acute Kidney Injury
3
2017
30
0.280
Why?
Remission Induction
5
2017
50
0.280
Why?
Anticoagulants
3
2018
151
0.280
Why?
Unsafe Sex
2
2013
9
0.280
Why?
Communication
6
2013
107
0.280
Why?
Infant
9
2017
711
0.280
Why?
Demography
6
2017
82
0.280
Why?
Vitamin K
2
2012
20
0.270
Why?
Multivariate Analysis
4
2011
266
0.270
Why?
Disease Progression
2
2018
320
0.250
Why?
Indians, North American
3
2011
462
0.250
Why?
T-Lymphocytes
2
2018
194
0.240
Why?
Cross-Sectional Studies
8
2013
527
0.240
Why?
Prognosis
6
2017
621
0.240
Why?
Non-Randomized Controlled Trials as Topic
1
2019
1
0.240
Why?
Anemia, Hemolytic
2
2017
14
0.240
Why?
Prednisone
5
2014
42
0.240
Why?
Thrombin
2
2003
34
0.230
Why?
Programmed Cell Death 1 Receptor
1
2018
31
0.230
Why?
Immunologic Factors
2
2016
32
0.230
Why?
Educational Status
2
2017
80
0.230
Why?
Antineoplastic Agents, Immunological
1
2018
17
0.230
Why?
Medical Oncology
2
2014
40
0.230
Why?
Medication Therapy Management
1
2018
14
0.220
Why?
Clinical Trials, Phase I as Topic
1
2018
15
0.220
Why?
Dose-Response Relationship, Drug
3
2018
480
0.220
Why?
HIV Infections
2
2012
159
0.220
Why?
Specialization
2
2018
28
0.220
Why?
Neoplasm Recurrence, Local
2
2018
290
0.220
Why?
Hospitalization
2
2013
111
0.220
Why?
Risk Assessment
3
2015
421
0.220
Why?
Antibodies, Monoclonal, Humanized
1
2018
84
0.220
Why?
United Kingdom
2
2015
34
0.220
Why?
Hematologic Neoplasms
1
2017
15
0.220
Why?
Research Design
3
2017
119
0.220
Why?
Public Health Surveillance
1
2017
6
0.210
Why?
Carcinoma, Mucoepidermoid
1
2017
9
0.210
Why?
Carcinoma, Adenoid Cystic
1
2017
15
0.210
Why?
Mobile Applications
1
2017
13
0.210
Why?
Multicenter Studies as Topic
1
2017
21
0.210
Why?
Practice Guidelines as Topic
2
2013
201
0.210
Why?
Interviews as Topic
8
2015
107
0.210
Why?
Contraceptive Agents
1
2016
3
0.210
Why?
Salivary Gland Neoplasms
1
2017
32
0.210
Why?
Lupus Erythematosus, Systemic
4
2015
843
0.210
Why?
Pregnancy Complications
1
2018
72
0.210
Why?
Family
2
2014
85
0.200
Why?
Insurance, Health
1
2017
55
0.200
Why?
Academies and Institutes
1
2016
5
0.200
Why?
Clostridium Infections
1
2017
37
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2018
113
0.200
Why?
Group Homes
1
2016
1
0.200
Why?
Isoantibodies
3
2013
13
0.200
Why?
Primary Myelofibrosis
1
2016
7
0.200
Why?
Positron-Emission Tomography
1
2017
91
0.200
Why?
Polycythemia Vera
1
2016
13
0.200
Why?
Leukemia, Myeloid, Acute
1
2017
42
0.200
Why?
Cell-Derived Microparticles
1
2016
9
0.200
Why?
Automobile Driving
1
2016
9
0.200
Why?
Surgical Wound Infection
1
2017
67
0.200
Why?
Pyrazoles
1
2016
34
0.200
Why?
Diabetes Complications
1
2016
49
0.200
Why?
Neoplasms
3
2018
463
0.200
Why?
Anti-Bacterial Agents
2
2017
302
0.200
Why?
Platelet Aggregation Inhibitors
2
2018
52
0.190
Why?
Clostridium difficile
1
2017
52
0.190
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2016
30
0.190
Why?
Peer Group
7
2012
26
0.190
Why?
Health Promotion
2
2010
131
0.190
Why?
Secondary Prevention
2
2016
40
0.190
Why?
Biomedical Research
1
2016
66
0.190
Why?
Odds Ratio
5
2016
211
0.190
Why?
Morbidity
2
2013
41
0.190
Why?
Standard of Care
1
2015
5
0.190
Why?
Severity of Illness Index
6
2015
317
0.190
Why?
Catheterization, Central Venous
3
2012
40
0.190
Why?
International Classification of Diseases
2
2012
23
0.190
Why?
Incidence
6
2016
401
0.190
Why?
Mastectomy, Segmental
1
2015
18
0.180
Why?
Protein Kinase Inhibitors
1
2016
109
0.180
Why?
Ribosomes
1
2015
18
0.180
Why?
Syndrome
4
2016
59
0.180
Why?
Guideline Adherence
1
2015
73
0.170
Why?
Lung Neoplasms
1
2018
290
0.170
Why?
Population Surveillance
2
2012
81
0.170
Why?
Culture
1
2014
20
0.170
Why?
Adenocarcinoma
1
2017
278
0.170
Why?
Violence
1
2014
23
0.170
Why?
Goals
1
2014
23
0.170
Why?
Albuminuria
1
2014
24
0.170
Why?
Carcinoma, Squamous Cell
1
2017
254
0.170
Why?
Palliative Care
1
2015
63
0.170
Why?
Smoking
4
2014
420
0.170
Why?
Obesity
1
2018
360
0.170
Why?
Drug Administration Schedule
2
2012
181
0.170
Why?
Tomography, X-Ray Computed
1
2017
430
0.170
Why?
Pregnancy Complications, Neoplastic
1
2014
6
0.170
Why?
Self Concept
1
2014
34
0.170
Why?
Depressive Disorder, Major
1
2015
68
0.170
Why?
Antibodies
2
2015
96
0.160
Why?
Recovery of Function
1
2014
63
0.160
Why?
Ethnic Groups
2
2011
118
0.160
Why?
Diarrhea
3
2010
48
0.160
Why?
Lung Diseases
1
2013
29
0.160
Why?
Predictive Value of Tests
4
2017
379
0.160
Why?
Income
2
2011
35
0.160
Why?
Social Conditions
1
2013
3
0.160
Why?
Conflict of Interest
1
2013
18
0.160
Why?
Neutropenia
1
2013
31
0.160
Why?
Benzamides
1
2003
14
0.160
Why?
Ambulatory Care
1
2013
60
0.150
Why?
Hispanic Americans
2
2011
247
0.150
Why?
Heart Diseases
2
2016
50
0.150
Why?
European Continental Ancestry Group
3
2011
435
0.150
Why?
Catheter-Related Infections
1
2012
6
0.150
Why?
Clinical Protocols
2
2017
34
0.150
Why?
Renal Veins
1
2012
5
0.150
Why?
Upper Extremity Deep Vein Thrombosis
1
2012
4
0.150
Why?
Brain Neoplasms
1
2015
188
0.150
Why?
Physicians
2
2014
87
0.150
Why?
Blood Coagulation Tests
1
2012
8
0.150
Why?
Kaplan-Meier Estimate
3
2018
167
0.150
Why?
Heparin, Low-Molecular-Weight
1
2012
17
0.150
Why?
Internal-External Control
2
2009
14
0.140
Why?
Interdisciplinary Communication
1
2012
29
0.140
Why?
Heparin
1
2012
50
0.140
Why?
Factor Xa Inhibitors
1
2012
29
0.140
Why?
Reproducibility of Results
2
2013
621
0.140
Why?
School Health Services
1
2012
26
0.140
Why?
Pancreatic Neoplasms
1
2016
349
0.140
Why?
Proportional Hazards Models
3
2016
163
0.140
Why?
Plateletpheresis
1
2011
2
0.140
Why?
Blood Donors
1
2011
4
0.140
Why?
Schools
1
2012
38
0.140
Why?
Blood Preservation
1
2011
5
0.140
Why?
Rho(D) Immune Globulin
3
2013
8
0.140
Why?
Cardiac Catheterization
1
2012
70
0.140
Why?
Survival Rate
4
2017
377
0.140
Why?
Cooperative Behavior
1
2012
74
0.140
Why?
Time Factors
5
2017
1165
0.140
Why?
Asian Americans
1
2011
45
0.140
Why?
Escherichia coli O157
2
2008
13
0.140
Why?
Smoking Cessation
1
2015
290
0.140
Why?
Fatigue
1
2011
30
0.140
Why?
Prevalence
6
2013
403
0.130
Why?
Escherichia coli Infections
2
2008
29
0.130
Why?
Social Marketing
1
2010
4
0.130
Why?
Methods
1
2010
6
0.130
Why?
Adverse Drug Reaction Reporting Systems
1
2010
6
0.130
Why?
Data Mining
1
2010
8
0.130
Why?
Patient Satisfaction
4
2017
71
0.130
Why?
United States Food and Drug Administration
1
2010
30
0.130
Why?
Pharmaceutical Preparations
1
2010
26
0.130
Why?
Gender Identity
1
2009
14
0.120
Why?
Breast Neoplasms
1
2015
409
0.120
Why?
Protease Inhibitors
1
2009
35
0.120
Why?
Alcoholism
2
2008
105
0.120
Why?
Health Surveys
4
2011
69
0.120
Why?
Epidemiologic Research Design
1
2009
7
0.120
Why?
Methicillin-Resistant Staphylococcus aureus
1
2009
20
0.120
Why?
Age Distribution
3
2015
75
0.120
Why?
Chemotherapy, Adjuvant
1
2009
100
0.120
Why?
Referral and Consultation
1
2009
74
0.110
Why?
Warfarin
1
2009
57
0.110
Why?
Memory
1
2008
65
0.110
Why?
Physical Endurance
1
2008
54
0.110
Why?
Enterocolitis
1
2007
4
0.110
Why?
Attention
1
2008
62
0.110
Why?
Monitoring, Physiologic
1
2007
39
0.110
Why?
Psychometrics
4
2013
96
0.110
Why?
Gastrointestinal Hemorrhage
1
2008
37
0.110
Why?
Primary Health Care
1
2009
111
0.110
Why?
Self-Help Groups
2
2007
10
0.110
Why?
Sexually Transmitted Diseases
1
2007
25
0.100
Why?
Community Health Services
1
2007
33
0.100
Why?
Pancreatitis
1
2007
33
0.100
Why?
Walking
1
2007
67
0.100
Why?
Risk
2
2017
113
0.100
Why?
Immune System Diseases
1
2006
3
0.100
Why?
von Willebrand Factor
2
2004
27
0.100
Why?
Immunosuppression
1
2006
14
0.100
Why?
Cognition
1
2008
135
0.100
Why?
Juvenile Delinquency
1
2005
2
0.100
Why?
Survival Analysis
2
2017
254
0.090
Why?
Aggression
1
2005
17
0.090
Why?
Diagnosis, Differential
4
2011
310
0.090
Why?
Hirsutism
1
2005
16
0.090
Why?
Hair
1
2005
13
0.090
Why?
Child Rearing
1
2005
8
0.090
Why?
Needs Assessment
1
2005
45
0.090
Why?
Data Collection
2
2017
119
0.090
Why?
Polycystic Ovary Syndrome
1
2005
35
0.090
Why?
Sensation Disorders
1
2004
1
0.090
Why?
Peripheral Nervous System Diseases
1
2004
18
0.090
Why?
Fever
2
2016
33
0.090
Why?
Poverty Areas
1
2004
7
0.090
Why?
Rural Health
1
2004
15
0.090
Why?
Monitoring, Ambulatory
1
2004
18
0.090
Why?
Fibrin Fibrinogen Degradation Products
1
2004
10
0.080
Why?
Physical Fitness
1
2004
42
0.080
Why?
Receptors, Thrombopoietin
2
2014
9
0.080
Why?
Pilot Projects
2
2017
232
0.080
Why?
Ovarian Neoplasms
1
2009
415
0.080
Why?
Cell Line, Tumor
2
2018
1051
0.080
Why?
Achievement
1
2003
6
0.080
Why?
Combined Modality Therapy
2
2015
276
0.080
Why?
Pulmonary Embolism
1
2004
67
0.080
Why?
Motor Activity
1
2004
110
0.080
Why?
Drug Therapy, Combination
1
2003
134
0.080
Why?
Lung
1
2004
148
0.080
Why?
Activated Protein C Resistance
1
2002
2
0.070
Why?
Factor V
1
2002
3
0.070
Why?
Thrombophilia
1
2002
10
0.070
Why?
Tobacco Use Cessation
1
2002
14
0.070
Why?
Academic Medical Centers
2
2012
58
0.070
Why?
HELLP Syndrome
1
2001
2
0.070
Why?
Enzyme Activation
2
2013
225
0.070
Why?
Peripheral Vascular Diseases
1
2002
24
0.070
Why?
Decision Making
1
2003
122
0.070
Why?
Choice Behavior
2
2013
26
0.070
Why?
Cause of Death
2
2013
57
0.070
Why?
Exercise
1
2004
215
0.070
Why?
Plasmapheresis
1
2001
3
0.070
Why?
Social Responsibility
2
2012
10
0.070
Why?
Students
1
2001
70
0.070
Why?
Bone Marrow Transplantation
1
2001
45
0.070
Why?
Diabetes Mellitus
2
2017
122
0.070
Why?
Drug Hypersensitivity
2
2016
19
0.070
Why?
Regression Analysis
2
2015
154
0.070
Why?
Renal Dialysis
2
2017
65
0.060
Why?
Smoking Prevention
1
2002
112
0.060
Why?
Urban Population
3
2006
65
0.060
Why?
Biopsy, Needle
1
2000
51
0.060
Why?
Patient Admission
1
2000
27
0.060
Why?
Bone Marrow
1
2000
58
0.060
Why?
Prostatic Neoplasms
1
2003
233
0.060
Why?
Factor Analysis, Statistical
2
2013
36
0.060
Why?
Mice, Obese
1
2018
14
0.060
Why?
Interview, Psychological
2
2013
16
0.060
Why?
Attitude of Health Personnel
1
2000
128
0.060
Why?
Oncologists
1
2018
5
0.060
Why?
Leptin
1
2018
41
0.060
Why?
Blood Coagulation
2
2003
45
0.060
Why?
Tumor Burden
1
2018
107
0.060
Why?
Species Specificity
1
2018
160
0.060
Why?
Cost-Benefit Analysis
1
2018
104
0.060
Why?
Algorithms
1
2001
347
0.060
Why?
Reference Values
1
2018
120
0.060
Why?
Dideoxynucleosides
1
2017
12
0.060
Why?
Pediatrics
1
2000
114
0.050
Why?
Body Weight
1
2018
145
0.050
Why?
Sexuality
1
2017
5
0.050
Why?
Immunotherapy
1
2018
81
0.050
Why?
Leisure Activities
2
2009
14
0.050
Why?
Safe Sex
1
2017
9
0.050
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2017
6
0.050
Why?
Cross-Over Studies
1
2017
69
0.050
Why?
Tissue Distribution
1
2017
110
0.050
Why?
Diet
1
2018
130
0.050
Why?
Neoplasm Grading
1
2017
89
0.050
Why?
Postpartum Period
1
2017
41
0.050
Why?
Gestational Age
1
2017
83
0.050
Why?
Diagnostic Errors
1
2017
34
0.050
Why?
Patient Compliance
1
2017
78
0.050
Why?
Remission, Spontaneous
1
2016
10
0.050
Why?
Lymphatic Metastasis
1
2017
173
0.050
Why?
Creatinine
2
2009
49
0.050
Why?
Maryland
1
2016
4
0.050
Why?
Statistics, Nonparametric
2
2010
80
0.050
Why?
CD52 Antigen
1
2016
2
0.050
Why?
Antigens, CD19
1
2016
9
0.050
Why?
Time-to-Treatment
1
2016
10
0.050
Why?
California
1
2016
44
0.050
Why?
Immunophenotyping
1
2016
46
0.050
Why?
Case-Control Studies
2
2010
649
0.050
Why?
Chills
1
2016
3
0.050
Why?
Antigens, Neoplasm
1
2016
39
0.050
Why?
Patient Outcome Assessment
1
2016
12
0.050
Why?
Causality
1
2016
10
0.050
Why?
Adaptation, Physiological
1
2017
110
0.050
Why?
Rhabdomyolysis
1
2016
6
0.050
Why?
Hematologic Diseases
1
2016
8
0.050
Why?
Respiratory Insufficiency
1
2016
12
0.050
Why?
Janus Kinase 2
1
2016
33
0.050
Why?
Nonprescription Drugs
1
2016
12
0.050
Why?
Program Development
1
2016
70
0.050
Why?
Self Efficacy
1
2016
48
0.050
Why?
Urban Health
2
2007
14
0.050
Why?
Chemical and Drug Induced Liver Injury
1
2016
17
0.050
Why?
Glycoproteins
1
2016
52
0.050
Why?
Blindness
1
2016
23
0.050
Why?
Hypoglycemia
1
2016
23
0.050
Why?
Beverages
1
2016
24
0.050
Why?
Self Report
1
2016
75
0.050
Why?
Antigens, CD
1
2016
101
0.050
Why?
Religion
2
2007
14
0.050
Why?
Convalescence
1
2015
6
0.050
Why?
Intelligence Tests
1
2015
21
0.050
Why?
Pentostatin
1
2015
4
0.050
Why?
Wisconsin
1
2015
9
0.050
Why?
Hospice Care
1
2015
8
0.050
Why?
Cell Proliferation
1
2018
632
0.050
Why?
Health Care Surveys
1
2015
79
0.050
Why?
Organoplatinum Compounds
1
2015
28
0.050
Why?
Deoxycytidine
1
2015
34
0.050
Why?
Radiotherapy, Adjuvant
1
2015
68
0.040
Why?
Ambulatory Care Facilities
1
2015
33
0.040
Why?
Medicaid
1
2015
60
0.040
Why?
Decision Support Techniques
1
2015
41
0.040
Why?
Vancomycin
1
2015
39
0.040
Why?
Motivation
1
2015
102
0.040
Why?
Radiosurgery
1
2015
38
0.040
Why?
Mice, Inbred C57BL
1
2018
994
0.040
Why?
Killer Cells, Natural
1
2015
53
0.040
Why?
B-Lymphocytes
1
2016
201
0.040
Why?
Medicare
1
2015
114
0.040
Why?
Interferon Type I
1
2015
67
0.040
Why?
Glomerular Filtration Rate
1
2014
30
0.040
Why?
Kidney Function Tests
1
2013
13
0.040
Why?
African Continental Ancestry Group
2
2005
67
0.040
Why?
Neoplasm Staging
1
2015
479
0.040
Why?
Japan
1
2013
19
0.040
Why?
Neuropsychological Tests
1
2015
164
0.040
Why?
International Agencies
1
2013
4
0.040
Why?
Mortality
1
2013
28
0.040
Why?
Consensus Development Conferences as Topic
1
2013
5
0.040
Why?
Financial Support
1
2013
10
0.040
Why?
Family Relations
1
2013
6
0.040
Why?
Renal Insufficiency
1
2013
26
0.040
Why?
Internationality
1
2013
16
0.040
Why?
Guinea Pigs
1
2003
45
0.040
Why?
Chi-Square Distribution
2
2004
134
0.040
Why?
Gene Expression
1
2015
384
0.040
Why?
Steroids
1
2013
34
0.040
Why?
Drug Evaluation, Preclinical
1
2003
50
0.040
Why?
Vascular Patency
1
2003
50
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2016
306
0.040
Why?
Platelet Activation
1
2003
30
0.040
Why?
Acute Disease
1
2013
124
0.040
Why?
Vasoconstriction
1
2003
34
0.040
Why?
Prothrombin
2
2003
4
0.040
Why?
Phenotype
1
2015
507
0.040
Why?
Animals
2
2018
6945
0.040
Why?
Carotid Arteries
1
2003
46
0.040
Why?
RNA, Messenger
1
2015
569
0.040
Why?
Outpatients
1
2012
30
0.040
Why?
Inpatients
1
2012
28
0.040
Why?
Chronic Disease
1
2013
165
0.040
Why?
Signal Transduction
1
2018
1010
0.040
Why?
Life Style
1
2012
63
0.030
Why?
Critical Care
1
2011
35
0.030
Why?
L-Lactate Dehydrogenase
2
2001
11
0.030
Why?
Gene Expression Regulation
1
2015
495
0.030
Why?
Rats, Sprague-Dawley
1
2003
483
0.030
Why?
Data Interpretation, Statistical
1
2010
53
0.030
Why?
Focus Groups
1
2010
59
0.030
Why?
Qualitative Research
1
2010
54
0.030
Why?
Kuwait
1
2010
4
0.030
Why?
Continental Population Groups
1
2010
85
0.030
Why?
Europe
1
2010
62
0.030
Why?
Aspirations (Psychology)
1
2009
3
0.030
Why?
Socialization
1
2009
7
0.030
Why?
Social Identification
1
2009
7
0.030
Why?
Karnofsky Performance Status
1
2009
10
0.030
Why?
Placebos
1
2009
40
0.030
Why?
Censuses
1
2009
4
0.030
Why?
Weight Loss
1
2009
37
0.030
Why?
Sampling Studies
1
2009
23
0.030
Why?
International Normalized Ratio
1
2009
19
0.030
Why?
Database Management Systems
1
2009
13
0.030
Why?
Fatal Outcome
1
2009
54
0.030
Why?
Disease-Free Survival
1
2009
282
0.030
Why?
Nervous System Diseases
1
2009
36
0.030
Why?
Staphylococcal Infections
1
2009
49
0.030
Why?
Rats
1
2003
1201
0.030
Why?
Switzerland
1
2008
5
0.030
Why?
Autopsy
1
2007
19
0.030
Why?
Confidence Intervals
1
2008
68
0.030
Why?
Cholestasis
1
2007
11
0.030
Why?
Program Evaluation
1
2007
134
0.020
Why?
Bone Marrow Cells
1
2007
69
0.020
Why?
Sports
1
2005
15
0.020
Why?
Education
1
2005
27
0.020
Why?
Cross-Cultural Comparison
1
2005
20
0.020
Why?
Ankle
1
2004
5
0.020
Why?
Proprioception
1
2004
4
0.020
Why?
Restless Legs Syndrome
1
2004
3
0.020
Why?
Touch
1
2004
7
0.020
Why?
Neurologic Examination
1
2004
11
0.020
Why?
Vitamin B 12 Deficiency
1
2004
13
0.020
Why?
Reflex
1
2004
16
0.020
Why?
Weights and Measures
1
2004
4
0.020
Why?
Postural Balance
1
2004
30
0.020
Why?
MEDLINE
1
2004
27
0.020
Why?
Ventilation-Perfusion Ratio
1
2004
4
0.020
Why?
Gait
1
2004
35
0.020
Why?
Tomography, Spiral Computed
1
2004
10
0.020
Why?
Radionuclide Imaging
1
2004
37
0.020
Why?
Vibration
1
2004
49
0.020
Why?
Transplantation, Homologous
1
2004
49
0.020
Why?
Models, Psychological
1
2004
68
0.020
Why?
Poverty
1
2004
63
0.020
Why?
Autoimmune Diseases
1
2005
131
0.020
Why?
Attitude to Health
1
2004
84
0.020
Why?
Disease Management
1
2003
56
0.020
Why?
Analysis of Variance
1
2004
320
0.020
Why?
Venous Thrombosis
1
2004
80
0.020
Why?
Information Dissemination
1
2003
23
0.020
Why?
Arthritis, Rheumatoid
1
2004
114
0.020
Why?
Body Mass Index
1
2004
293
0.020
Why?
Amino Acids
1
2003
50
0.020
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2002
1
0.020
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2002
2
0.020
Why?
3' Untranslated Regions
1
2002
36
0.020
Why?
Sensitivity and Specificity
1
2004
494
0.020
Why?
Vascular Endothelial Growth Factor A
1
2003
159
0.020
Why?
Random Allocation
1
2002
86
0.020
Why?
Peptide Fragments
1
2003
171
0.020
Why?
Microcirculation
1
2002
61
0.020
Why?
Gene Frequency
1
2002
158
0.020
Why?
Histocompatibility
1
2001
4
0.020
Why?
Social Class
1
2002
70
0.020
Why?
Aphasia, Broca
1
2001
1
0.020
Why?
Graft vs Host Disease
1
2001
21
0.020
Why?
Interleukin-6
1
2003
138
0.020
Why?
Amnesia
1
2001
7
0.020
Why?
Infection
1
2001
20
0.020
Why?
False Positive Reactions
1
2001
35
0.020
Why?
Pain
1
2001
76
0.020
Why?
Kidney Failure, Chronic
1
2001
54
0.020
Why?
Alleles
1
2002
319
0.020
Why?
Fungemia
1
2000
1
0.020
Why?
Polymerase Chain Reaction
1
2002
283
0.020
Why?
Postoperative Complications
1
2004
369
0.020
Why?
Genotype
1
2002
438
0.020
Why?
Bacteremia
1
2000
50
0.020
Why?
Muscle, Skeletal
1
2001
318
0.010
Why?
Vesely's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_